NOF Corp - Company Profile
Powered by 
All the sales intelligence you need on NOF Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how NOF Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with NOF Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
NOF Corp (NOF) operates in various sectors including functional chemicals, pharmaceuticals, medical care, health, and chemicals, along with transportation and real estate activities. Its main products encompass fatty acids, surfactants, ethylene oxide derivatives, and electronic materials, among others. NOF’s explosives and propulsion product line includes various types of solid propellant for rockets, electric detonators and industrial explosives, ocean exploitation equipment and defense related explosives. Its life science products include diagnostic reagents, coating material for medical devices, products for eye care oral care and fiber processing agents. It also offers functional films, electronic materials and anti-corrosion materials. The company's products serve a diverse range of industries, providing solutions for medical, industrial, and consumer applications. It has a global presence with subsidiaries and affiliates in regions including North America, Europe, and Asia. NOF is headquartered in Tokyo, Japan.
Headquarters
Japan
Address
Yebisu Garden Place Tower, 4-20-3, Ebisu, Shibuya-Ku, Tokyo, 150-6012
Website
www.nof.co.jp
Telephone
81 3 54246600
No of Employees
3,997
Industry
Chemicals
Ticker Symbol & Exchange
4403 (TYO)
Revenue (2025)
$1.6B
7.2%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
7.4%
(2025 vs 2024)
Market Cap*
$4.0B
Net Profit Margin (2025)
XYZ
0.2%
(2025 vs 2024)
* As of and is in US$
NOF Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Oleo and Specialty Chemicals | Lipidure |
| Fats and Glycerin | Unister |
| Petrochemicals | Alflow |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Financing Agreements | In August, the company invested in Phosphorex. |
| 2024 | Financing Agreements | In January, the company announced an investment in UMI Investment Limited Partnership. |
| 2023 | Contracts/Agreements | In August, the company entered into an agreement with Jellicle Co and Tetra for the production of cell culture scaffolding material using cell-adhesive polyethylene glycol (PEG) gel. |
Competitor Comparison
| Key Parameters | NOF Corp | Adeka Corp | Nifco Inc | Nissan Chemical Corp | Sumitomo Seika Chemicals Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Shibuya-Ku | Arakawa-ku | Yokosuka-Shi | Chuo-Ku | Osaka-Shi |
| State/Province | Tokyo | Tokyo | Kanagawa | Tokyo | Osaka |
| No. of Employees | 3,997 | 5,453 | 9,041 | 3,283 | 1,413 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Takeo Miyaji | Chief Executive Officer; Chairman | Executive Board | 2023 | 58 |
| Koji Sawamura | Chief Executive Officer; Director; President | Executive Board | 2023 | 60 |
| Kazuyoshi Yamauchi | Head of Information Systems Group; General Manager- Corporate Technical Division; Executive Operating Officer; Director; Chief Safety and Quality Officer | Executive Board | 2023 | 63 |
| Manabu Saito | Chief Compliance Officer; Executive Operating Officer; Head - Functional Foods Group, HR & General affairs Group, and Legal Group | Senior Management | 2023 | 64 |
| Naoya Umehara | Chief Financial Officer; Executive Operating Officer- Corporate Communications Group, and Finance Group; Head - Corporate Planning & Strategy Group | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer